Target intelligence / Profile preview

RNA, U6 small nuclear 1024, pseudogene (RNU6-1024P)

Target
RNU6-1024P
Molecular classification
Other (non-coding RNA, pseudogene)
01

Overview

RNU6-1024P is a pseudogene corresponding to a small nuclear RNA gene, annotated as "RNA, U6 small nuclear 1024, pseudogene." It is non-coding and does not produce a functional RNA or protein product[1][6]. U6 small nuclear RNAs are normally part of the spliceosome involved in pre-mRNA splicing, but pseudogenes like RNU6-1024P are considered non-functional remnants of gene duplication or retrotransposition events. Although most pseudogenes are thought to be transcriptionally silent, a subset have been reported to regulate their functional gene counterparts via mechanisms such as serving as microRNA decoys or sources of small interfering RNAs (siRNAs)[3]. However, there is no evidence that RNU6-1024P itself participates in such regulatory functions, nor is it a known drug target or biomarker. Summary of status: RNU6-1024P is not considered a therapeutic or classical molecular target. It is correctly named as a pseudogene and classified as a non-coding, non-functional RNA locus with no direct roles in disease or therapy[1][6]. The locus is included in genomic databases as a remnant of U6 small nuclear RNA gene evolution. If your aim is to identify actionable therapeutic targets, this entry should be excluded.

Other names
RNU6-1024P
02

Biological functions

None specific to this locus; general pseudogene effects may include gene regulation (as microRNA decoy, source of siRNA, or antisense regulation)
03

Disease associations

None known for this locus; some pseudogenes in other contexts can modulate gene expression in cancer or other diseases

Beyond the preview

Go deeper on RNA, U6 small nuclear 1024, pseudogene (RNU6-1024P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1024, pseudogene (RNU6-1024P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call